Thyroid Neoplasms Clinical Trials

11 recruiting

Frequently Asked Questions

Common questions about Thyroid Neoplasms clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 111 of 11 trials

Recruiting

Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms

Endocrine TumorsNeuroblastomaThyroid Neoplasms+2 more
National Cancer Institute (NCI)2,415 enrolled1 locationNCT01005654
Recruiting
Not Applicable

EMDR Integrative Group Protocol and Individual Treatment for Patients With Cancer: A Pilot Study

NeoplasmPsychological DistressPost Traumatic Stress Disorder (PTSD)+1 more
Università Cattolica di Milano25 enrolled1 locationNCT07447089
Recruiting

Response to Neoadjuvant Treatment in Locally Advanced Thyroid Cancer

Thyroid CancerThyroid Neoplasms
Fujian Medical University120 enrolled1 locationNCT07419932
Recruiting
Not Applicable

Testing a Web-based Intervention for Radioactive Iodine Symptom Management to Improve Health-related Quality of Life Among Differentiated Thyroid Cancer Patients

Thyroid Neoplasms
Georgetown University88 enrolled1 locationNCT06853925
Recruiting

Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions

ParagangliomaPheochromocytomaKidney Neoplasms+5 more
The University of Texas Health Science Center at San Antonio2,000 enrolled1 locationNCT03160274
Recruiting
Not Applicable

TRAIL Study: Feasibility and Pilot

Thyroid CancerThyroid NoduleThyroid Neoplasms
Dartmouth-Hitchcock Medical Center20 enrolled1 locationNCT06220656
Recruiting
Not Applicable

Hybrid Endoscopic Hemithyroidectomy and Targeted Ablation for Bilateral Papillary Thyroid Carcinoma

Thyroid NeoplasmsCarcinoma, Papillary
Fujian Medical University60 enrolled1 locationNCT07033572
Recruiting

Dual-Channel Near-Infrared Autofluorescence Imaging and AI Analysis to Locate Parathyroid Glands (PTFinder)

Thyroid NeoplasmsHyperparathyroidismParathyroid Gland
Bo Wang,MD180 enrolled1 locationNCT07010380
Recruiting
Not Applicable

Dual-port Trans-subclavian Thyroid Endoscopic Surgery

Endoscopic SurgeryThyroid Neoplasms
First Affiliated Hospital of Wenzhou Medical University300 enrolled1 locationNCT06398795
Recruiting

Study of Anlotinib Hydrochloride Capsules in the Treatment of Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Carcinoma

Thyroid Neoplasms
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.380 enrolled3 locationsNCT05994365
Recruiting

Institut Paoli Calmettes Thyroid Cancer Database

Thyroid Neoplasms
Institut Paoli-Calmettes3,000 enrolled1 locationNCT02869620